Thyroid eye disease (TED) is an inflammatory condition affecting those with thyroid disease. There is no cure, but effective management strategies exist. Thyroid eye disease, or Graves’ ophthalmopathy ...

Thyroid eye disease is a chronic condition that causes inflammation in your eyes. It affects about 25–50% of people with Graves’ disease, which is an autoimmune disorder that causes an overactive ...

Graves’ disease is an autoimmune disorder that primarily affects the thyroid gland. Approximately 27 percent of patients with Graves’ disease in North America will develop an eye disease that is known ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Please provide your email address to receive an email when new articles are posted on . Thyroid eye disease treatments have evolved significantly in recent years. Work is still needed to find durable, ...

Thyroid eye disease can cause eye pain, dryness, and eyelids that do not fully close. These symptoms can disrupt sleep. When your eyes stay partly open at night, light and dryness can make it harder ...

Dear Doctors: Lately, we’ve been seeing a lot of ads on TV for a medication to treat thyroid eye disease. My daughter, who is 23, suffers from dry eyes, and now she’s sure she has it. What is thyroid ...

As mentioned in Overview, most thyroid eye disease (TED) cases are closely related to hyperthyroidism. Approximately 85% of patients with TED develop the disease around 18 months before or after the ...

Patients with autoimmune thyroiditis who use semaglutide to manage their T2D have fewer TED-related diagnoses at 5 years.

Q: Lately, we've been seeing a lot of ads on TV for a medication to treat thyroid eye disease. My daughter, who is 23, suffers from dry eyes, and now she's sure she has it. What is thyroid eye disease ...

Fibroblasts from patients with TED secrete active PAPP-A and are stimulated by proinflammatory cytokines, namely tumor necrosis factor (TNF)-α and interleukin (IL)-1β. Novel therapeutic agents may be ...

The most useful biomarker for extraocular muscle enlargement in thyroid eye disease (TED) is unclear. According to this study, higher thyroid-stimulating antibody (TSAb) levels and older age were ...